-
Product Insights
Da Dang 2 Solar PV Park
Da Dang 2 Solar PV Park is a solar PV project located in Lam Dong, Vietnam. The project is at the permitting stage. Empower your strategies with our Da Dang 2 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Company Insights
Innovation and Patenting activity of Chong Kun Dang Pharmaceutical Corporation Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Chong Kun Dang Pharmaceutical Corporation Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Company Insights
Innovation and Patenting activity of Chong Kun Dang Holdings Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Chong Kun Dang Holdings Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Company Insights
Innovation and Patenting activity of Sam Chun Dang Pharm Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Sam Chun Dang Pharm Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Empagliflozin + Metformin + Sitagliptin) in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Empagliflozin + Metformin + Sitagliptin) in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Empagliflozin + Metformin + Sitagliptin) in Type...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CFT-7455 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CFT-7455 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CFT-7455 in Relapsed Multiple Myeloma Drug Details: CFT-7455 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CFT-7455 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CFT-7455 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CFT-7455 in Refractory Multiple Myeloma Drug Details: CFT-7455 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Emactuzumab in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Emactuzumab in Epithelial Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Emactuzumab in Epithelial Ovarian Cancer Drug Details: Emactuzumab (RG-7155, RO5509554) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CKD-331 in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CKD-331 in Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CKD-331 in Hypertension Drug Details: CKD-331 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CKD-331 in Hyperlipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CKD-331 in Hyperlipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CKD-331 in Hyperlipidemia Drug Details: CKD-331 is under development for the treatment of...